SCHEMBL6153668

SCHEMBL6153668

O=C(C=Cc1ccccc1)N[C@@H]1CN2CCC1CC2

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 5/20 0.59
HPGD P15428 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
CHRM2 P08172 2/20 0.55
CHRM1 P11229 2/20 0.55
CHRM3 P20309 2/20 0.55
HTR3E A5X5Y0 3/20 0.50
HTR3B O95264 3/20 0.50
HTR3A P46098 3/20 0.50
HTR3D Q70Z44 3/20 0.50
HTR3C Q8WXA8 3/20 0.50
DRD2 P14416 1/20 0.49
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49
HTR2B P41595 1/20 0.49
SIGMAR1 Q99720 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153661 1.00 CHRNA7 (0.59) CHRNA7HPGDSMN1; SMN2CHRM2CHRM1
SCHEMBL374846 1.00 CHRNA7 (0.59) CHRNA7HPGDSMN1; SMN2CHRM2CHRM1
SCHEMBL6153288 1.00 CHRNA7 (0.59) CHRNA7HPGDSMN1; SMN2CHRM2CHRM1
SCHEMBL5987468 1.00 CHRNA7 (0.59) CHRNA7HPGDSMN1; SMN2CHRM2CHRM1
SCHEMBL374845 1.00 CHRNA7 (0.59) CHRNA7HPGDSMN1; SMN2CHRM2CHRM1
SCHEMBL6152691 1.00 CHRNA7 (0.59) CHRNA7HPGDSMN1; SMN2CHRM2CHRM1
SCHEMBL6152807 1.00 CHRNA7 (0.59) CHRNA7HPGDSMN1; SMN2CHRM2CHRM1
SCHEMBL9411988 0.89 CHRNA7 (0.51) CHRNA7HPGDSMN1; SMN2CHRM2CHRM1
SCHEMBL9412007 0.88 MMP1 (0.49) CHRNA7HPGDSMN1; SMN2CHRM2CHRM1
SCHEMBL6152859 0.87 CHRM3 (0.47) CHRNA7HPGDSMN1; SMN2CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1233964-B1 NEW USE AND NOVEL N-AZABICYCLO-AMIDE DERIVATIVES ASTRAZENECA AB (SE) 2005-06-22 EP claimed
EP-1233964-B1 NEW USE AND NOVEL N-AZABICYCLO-AMIDE DERIVATIVES ASTRAZENECA AB (SE) 2005-06-22 EP disclosed
US-6683090-B1 N-(1-AZABICYCLO(2.2.2)OCT-3-YL)PROPENAMIDE DERIVATIVES; PSYCHOTIC AND INTELLECTUAL IMPAIRMENT DISORDERS ASTRAZENECA AB (SE) 2004-01-27 US disclosed